| Publication | Date of Publication | Type |
|---|
Flexible evaluation of surrogate markers with Bayesian model averaging
Statistics in Medicine | 2024-10-31 | Paper |
Using a surrogate with heterogeneous utility to test for a treatment effect
Statistics in Medicine | 2024-10-30 | Paper |
Quantifying the feasibility of shortening clinical trial duration using surrogate markers
Statistics in Medicine | 2024-10-29 | Paper |
Quantifying the bias due to observed individual confounders in causal treatment effect estimates
Statistics in Medicine | 2024-10-29 | Paper |
Estimation of the proportion of treatment effect explained by a high-dimensional surrogate
Statistics in Medicine | 2024-10-29 | Paper |
A rank-based approach to evaluate a surrogate marker in a small sample setting
Biometrics | 2024-10-28 | Paper |
Assessing heterogeneity in surrogacy using censored data
Statistics in Medicine | 2024-10-14 | Paper |
| SurrogateBMA | 2024-02-01 | Software |
Flexible evaluation of surrogate markers with Bayesian model averaging
Statistics in Medicine | 2023-12-11 | Paper |
Evaluating multiple surrogate markers with censored data
Biometrics | 2023-10-30 | Paper |
Robust methods to correct for measurement error when evaluating a surrogate marker
Biometrics | 2023-10-30 | Paper |
Discussion of “A Risk-Based Measure of Time-Varying Prognostic Discrimination for Survival Models,” by C. Jason Liang and Patrick J. Heagerty
Biometrics | 2023-10-30 | Paper |
Robust Approach to Combining Multiple Markers to Improve Surrogacy
Biometrics | 2023-10-30 | Paper |
Testing for Heterogeneity in the Utility of a Surrogate Marker
Biometrics | 2023-10-30 | Paper |
Evaluation of longitudinal surrogate markers
Biometrics | 2023-10-12 | Paper |
| longsurr | 2022-09-29 | Software |
| OSsurvival | 2022-09-29 | Software |
Robust approach to combining multiple markers to improve surrogacy
Biometrics | 2022-05-17 | Paper |
Estimation of the proportion of treatment effect explained by a high‐dimensional surrogate
Statistics in Medicine | 2022-02-21 | Paper |
| SurrogateTest | 2021-11-16 | Software |
| SBdecomp | 2021-11-15 | Software |
| SurrogateOutcome | 2021-11-15 | Software |
Quantifying the feasibility of shortening clinical trial duration using surrogate markers
Statistics in Medicine | 2021-09-02 | Paper |
Evaluating incremental values from new predictors with net reclassification improvement in survival analysis
Risk Assessment and Evaluation of Predictions | 2021-04-20 | Paper |
Using a surrogate marker for early testing of a treatment effect
Biometrics | 2020-09-16 | Paper |
Evaluation of longitudinal surrogate markers
Biometrics | 2020-06-22 | Paper |
Quantifying the bias due to observed individual confounders in causal treatment effect estimates
Statistics in Medicine | 2020-05-10 | Paper |
Assessing the value of a censored surrogate outcome
Lifetime Data Analysis | 2020-04-03 | Paper |
Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker
Biometrika | 2020-04-01 | Paper |
Using a surrogate marker for early testing of a treatment effect
Biometrics | 2019-09-02 | Paper |
Assessing the value of a censored surrogate outcome
Lifetime Data Analysis | 2019-04-12 | Paper |
Landmark estimation of survival and treatment effect in a randomized clinical trial
Journal of the American Statistical Association | 2017-08-04 | Paper |
Landmark estimation of survival and treatment effects in observational studies
Lifetime Data Analysis | 2017-06-06 | Paper |
Evaluating incremental values from new predictors with net reclassification improvement in survival analysis
Lifetime Data Analysis | 2015-10-16 | Paper |
Landmark prediction of long-term survival incorporating short-term event time information
Journal of the American Statistical Association | 2013-01-31 | Paper |
Incorporating short-term outcome information to predict long-term survival with discrete markers
Biometrical Journal | 2011-04-06 | Paper |
